Physician profile
Vivekkumar Patel
NPI 1649531617
$4,222.42
in general payments reported to CMS, 2019-2025
9 companies · $1,913 in 2025
The $1,913 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.64 · 2021: $395 · 2022: $109 · 2023: $1,485 · 2024: $235 · 2025: $1,913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,549 · Food and Beverage: $1,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,549.19 |
| Food and Beverage | $1,084.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,027.56 | 2021-2025 | Mitris Resilia Mitral Valve |
| Atricure, INC. | $1,452.57 | 2021-2023 | |
| Abiomed | $281.85 | 2025 | |
| W. L. Gore & Associates, INC. | $119.17 | 2024 | Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Boston Scientific Corporation | $115.98 | 2024 | |
| Intuitive Surgical, INC. | $84.64 | 2019 | |
| Stryker Corporation | $83.39 | 2021 | |
| Baxter Healthcare | $31.52 | 2023 | Preveleak |
| Solventum Corporation | $25.74 | 2025 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivekkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.